NASDAQ:BGNE - Beigene Stock Price, Price Target & More

Beigene trades on the NASDAQ under the ticker symbol "BGNE."

Beigene Ltd (NASDAQ:BGNE) announced its quarterly earnings results on Wednesday, May, 9th. The company reported ($2.03) EPS for the quarter, missing the Zacks' consensus estimate of ($1.62) by $0.41. The company had revenue of $32.54 million for the quarter, compared to analyst estimates of $16.88 million. During the same quarter in the prior year, the business posted ($1.27) EPS. View Beigene's Earnings History.

Beigene is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Beigene.

8 brokers have issued 12-month price targets for Beigene's stock. Their forecasts range from $86.00 to $225.00. On average, they expect Beigene's stock price to reach $170.1667 in the next year. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Ratings for Beigene.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beigene in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Beigene include Takeda Pharmaceutical (TKPYY), ASTELLAS PHARMA/ADR (ALPMY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), GRIFOLS S A/S (GRFS), Merck KGaA (MKGAF), Ono Pharmaceutical (OPHLF), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Genmab A/S (GNMSF) and Alnylam Pharmaceuticals (ALNY).

(BGNE) raised $126 million in an initial public offering on Wednesday, February 3rd 2016. The company issued 5,500,000 shares at a price of $22.00-$24.00 per share. Goldman Sachs, Morgan Stanley and Cowen and Company acted as the underwriters for the IPO and Baird was co-manager.

News headlines about BGNE stock have trended somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Beigene earned a media sentiment score of 0.13 on Accern's scale. They also assigned news stories about the company an impact score of 46.38 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Beigene's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (0.16%), Bank of Montreal Can (0.03%), Fox Run Management L.L.C. (0.01%) and World Asset Management Inc (0.00%). Company insiders that own Beigene stock include Amy C Peterson, Bros Advisors Lp Baker, Donald W Glazer, Howard Liang, Jane Huang, Ji Li, John Oyler, Thomas Malley and Xiaodong Wang. View Institutional Ownership Trends for Beigene.

BGNE stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co. and World Asset Management Inc. Company insiders that have sold Beigene company stock in the last year include Amy C Peterson, Howard Liang, Jane Huang, Ji Li and John Oyler. View Insider Buying and Selling for Beigene.

BGNE stock was purchased by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C. and Bank of Montreal Can. Company insiders that have bought Beigene stock in the last two years include Bros Advisors Lp Baker and Thomas Malley. View Insider Buying and Selling for Beigene.

Shares of BGNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BGNE stock can currently be purchased for approximately $165.05.

Beigene has a market capitalization of $8.82 billion and generates $238.39 million in revenue each year. The company earns $-93,100,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. Beigene employs 900 workers across the globe.

Beigene's mailing address is 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9, KY1-1108. The company can be reached via phone at 34-59-494-12 or via email at [email protected]